Aarti Drugs Ltd share price logo

Aarti Drugs Ltd Share Price (AARTIDRUGS)

₹494.750.85%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Overview of Aarti Drugs Ltd

Key events for Aarti Drugs Ltd

  • Aarti Drugs Stock Up by 12% in a Week - 05 Apr, 2024

    Aarti Drugs' stock has risen by 12% over the last week. The company's key performance indicators, including ROE, earnings growth, and dividend payout ratio, suggest good performance with high return on reinvested profits and expected future growth.

  • Aarti Drugs Announces Resignation of Independent Directors - 29 Mar, 2024

    Krishnacharya Govindacharya Akamanchi, Navin Chapshi Shah and Priti Paras Savla have ceased to be independent directors of Aarti Drugs Ltd upon completion of their second term on March 31, 2024. The board has approved the reconstitution of committees effective April 1, 2024.

Analyst Rating for Aarti Drugs Ltd stock

based on 1 analysts

BUY
100.00%
Buy
0.00%
Hold
0.00%
Sell

Based on 1 analysts offering long term price targets for Aarti Drugs Ltd. An average target of ₹562

Source: S&P Global Market Intelligence

Aarti Drugs Ltd share Performance

  • ₹487.05
    ₹499.45
    ₹494.75
    downward going graph

    1.56%

    Downside

    Day's Volatility:2.51%

    Upside

    0.95%

    downward going graph
  • ₹405.1
    ₹645.75
    ₹494.75
    downward going graph

    18.12%

    Downside

    52 Weeks Volatility:48.64%

    Upside

    30.52%

    downward going graph
1 Month Return8.31 %
3 Month Return-7.9 %
1 Year Return18.49 %
Previous Close₹490.60
Open₹490.60
Volume81.84K
Upper Circuit-
Lower Circuit-
Market Cap₹4,510.33Cr

Aarti Drugs Ltd Company Information

Aarti Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals. Part of the USD 1500 million Aarti Group, it has two RD divisions in Tarapur and Turbhe, Maharashtra; and three wholly-owned subsidiaries, namely Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA, a foreign subsidiary. It has expanded its production capacity from 598,000kg in 1993 to 25,716,000kg in 2021. In 2020 it incorporated two overseas subsidiaries and one domestic one, while the one in 2021 was wound up as it didn’t have any business activity. Aarti Drugs also carries out research and development on key products such as antihistaminic/antiallergic, antiinflammatory and antidiabetic. Its GMP-certified plant can manufacture Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. With 50 compounds formed for Antibiotics, Anti Protozoal, AntiInflammatory, Antidiabetic, Anti Fungal and Cardioprotectant therapeutic segments, it is a market leader in API segment.

Share Price: ₹494.75 per share as on 16 Apr, 2024 04:01 PM
Market Capitalisation: ₹4,510.33Cr as of today
Revenue: ₹605.94Cr as on December 2023 (Q4 23)
Net Profit: ₹36.71Cr as on December 2023 (Q4 23)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
OrganisationAarti Drugs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Fundamentals of Aarti Drugs Ltd

Insights on Aarti Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 33.79% to 35.17% in Dec 2023 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 138.4% return, outperforming this stock by 168.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 54.2% return, outperforming this stock by 35.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 56.09 Cr → 36.67 Cr (in ₹), with an average decrease of 13.1% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.33% to 2.10% in Dec 2023 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 5.22% to 5.18% in Dec 2023 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 743.28 Cr → 607.61 Cr (in ₹), with an average decrease of 6.4% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, AARTIDRUGS stock has moved down by -30.1%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 58.56% to 57.47% in Dec 2023 quarter

Aarti Drugs Ltd Valuation

Aarti Drugs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.29x)

March 31, 2020

Today (25.12x)

April 15, 2024

Industry (61.59x)

April 15, 2024

Highest (57.24x)

August 24, 2020

LowHigh

Aarti Drugs Ltd Mutual Fund Holdings

Funds Holdings
DSP Small Cap Fund Direct Plan GrowthDSP Small Cap Fund Direct Plan Growth1.27%
DSP Healthcare Fund Direct GrowthDSP Healthcare Fund Direct Growth1.36%
DSP Value Fund Direct Plan GrowthDSP Value Fund Direct Plan Growth0.38%
Motilal Oswal Nifty Microcap 250 Index Fund Direct GrowthMotilal Oswal Nifty Microcap 250 Index Fund Direct Growth0.26%
Groww Nifty Total Market Index Fund Direct GrowthGroww Nifty Total Market Index Fund Direct Growth0.01%

Aarti Drugs Ltd Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
57.47%
-1.87
Foreign Institutions
2.1%
-9.71
Mutual Funds
5.18%
-0.73
Retail Investors
35.17%
4.09
Others
0.08%
-21.77

Technicals of Aarti Drugs Ltd share

News & Events of Aarti Drugs Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Aarti Drugs Ltd shares.

Aarti Drugs Ltd (AARTIDRUGS) share price today is ₹494.75

Aarti Drugs Ltd is listed on NSE

Aarti Drugs Ltd is listed on BSE

  • Today’s highest price of Aarti Drugs Ltd is ₹499.45.
  • Today’s lowest price of Aarti Drugs Ltd is ₹487.05.

PE Ratio of Aarti Drugs Ltd is 25.12

PE ratio = Aarti Drugs Ltd Market price per share / Aarti Drugs Ltd Earnings per share

Today’s traded volume of Aarti Drugs Ltd(AARTIDRUGS) is 81.84K.

Today’s market capitalisation of Aarti Drugs Ltd(AARTIDRUGS) is ₹4510.33Cr.

Aarti Drugs Ltd(AARTIDRUGSPrice
52 Week High
₹645.75
52 Week Low
₹405.1

Aarti Drugs Ltd(AARTIDRUGS) share price is ₹494.75. It is down -23.38% from its 52 Week High price of ₹645.75

Aarti Drugs Ltd(AARTIDRUGS) share price is ₹494.75. It is up 22.13% from its 52 Week Low price of ₹405.1

Aarti Drugs Ltd(AARTIDRUGSReturns
1 Day Returns
4.15%
1 Month Returns
8.31%
3 Month Returns
-7.9%
1 Year Returns
18.49%